Clinical Trials on Benign Prostatic Hyperplasia

Total 8922 results

University of Washington
GlaxoSmithKline; VA Office of Research and Development; Seattle Institute for... and other collaborators

Completed

TRADE-Testosterone Replacement and Dutasteride Effectiveness (TRADE)

Benign Prostatic Hyperplasia | Hypogonadism

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Benign Prostatic Hyperplasia | Prostate Carcinoma

United States
University Hospital, Bordeaux

Recruiting

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction (PARTURP)

Benign Prostatic Hyperplasia

France
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Benign Prostatic Hyperplasia | BPH | LUTS | Lower Urinary Tract Symptoms (LUTS)

United States
Eli Lilly and Company

Completed

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (COMORBID©)

Benign Prostatic Hyperplasia | Erectile Dysfunction

United States, France, Italy, Greece, Mexico, Portugal, Canada, Germany, Russian Federation
Dong-A Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Korea, Republic of
Dr Vincent Misrai
Boston Scientific Corporation; Iqvia Pty Ltd

Recruiting

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP)

Benign Prostatic Hyperplasia | Anticoagulant Adverse Reaction

France
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
ProstaCare Pty Ltd

Not yet recruiting

Neuflo System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
ProArc Medical

Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH (Omega)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Georgia
Société Internationale d'Urologie

Recruiting

BPH Global Registry

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada, Italy, United Kingdom, Cyprus, United States, Chile
ProArc Medical

Recruiting

Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Israel
St. Joseph's Healthcare Hamilton

Not yet recruiting

Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.

Overactive Bladder | Benign Prostatic Hyperplasia

Canada
Samsung Medical Center

Completed

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Overactive Bladder | Benign Prostatic Hyperplasia

Korea, Republic of
Salzburger Landeskliniken

Unknown

Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate

Benign Prostatic Hyperplasia | Bladder Outlet Obstruction

Austria, Switzerland
EMS

Recruiting

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | Erectile Dysfunction

Brazil
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Takeda

Withdrawn

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Mexico
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)

Taiwan
Assistance Publique Hopitaux De Marseille

Completed

Prostate Cancer Antigen 3 (PCA-3) Gene Project

Prostate Cancer | Benign Prostatic Hypertrophy

France
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Astellas Pharma Taiwan, Inc.

Completed

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Overactive Bladder | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

Taiwan
Dr. J. Curtis Nickel
University of California, Los Angeles; The Cleveland Clinic

Terminated

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Benign Prostatic Hyperplasia | Chronic Prostatitis

Canada
Centre hospitalier de l'Université de Montréal...
PROCEPT BioRobotics

Recruiting

AQUABEAM® Robotic System and Ultrasound Accessories (AQUA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
Amna A. Desouky, MD

Active, not recruiting

Outcome of Conducting Self-management Intervention on Severity of Lower Urinary Tract Symptoms

Benign Prostatic Hyperplasia

Egypt
Samsung Medical Center

Completed

Evaluation of Symptom-specific Goal Achievement

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (PLUS)

Overactive Bladder | Benign Prostatic Hyperplasia

United States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
University of California, San Francisco
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

PRescription Exercise for Older Men With Urinary Disease (PROUD)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Guang'anmen Hospital of China Academy of Chinese...

Recruiting

Effect of Electroacupuncture on Benign Prostatic Hyperplasia (EABPH)

Benign Prostatic Hyperplasia

China
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
Thunder Bay Regional Health Research Institute
Northern Ontario School of Medicine

Active, not recruiting

Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
Thunder Bay Regional Health Research Institute
Northern Ontario School of Medicine; Thunder Bay Regional Health Sciences Centre

Active, not recruiting

Greenlight Vaporization vs Xpeeda Vaporesection

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
Mansoura University

Active, not recruiting

Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB

Overactive Bladder | Benign Prostatic Hyperplasia

Egypt
Centre Hospitalier Universitaire de Nice

Completed

Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours (PRECOCE)

Benign Prostatic Hypertrophy

France
Selcuk University

Suspended

Comparison of Different Energy Sources During TUR-P

Benign Prostatic Hypertrophy

Turkey
University Hospital, Tours

Completed

Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound (PROPIL)

Prostatic Hypertrophy, Benign

France
Yonsei University

Completed

The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly

Benign Prostatic Hypertrophy

Korea, Republic of
AEterna Zentaris

Completed

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) (AEZS-102-Z041)

Benign Prostatic Hypertrophy

United States, Canada
Azienda Ospedaliero Universitaria Maggiore della...

Recruiting

Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial (ProSeRePEA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Obstruction

Italy
Resurge Therapeutics Inc.

Recruiting

RT-310 Dose Escalation BPH Study

Lower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)

New Zealand, Australia
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS

Korea, Republic of
University of California, San Francisco

Completed

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Prostate Cancer | Nonmalignant Neoplasm

United States
Elpen Pharmaceutical Co. Inc.

Completed

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (PROSPERITY)

Benign Prostatic Hyperplasia

Greece
Jeil Pharmaceutical Co., Ltd.

Completed

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Overactive Bladder | Benign Prostatic Hyperplasia | LUTS
Bayer

Completed

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Prostatic Hypertrophy, Benign

Germany
North Florida/South Georgia Veterans Health System

Completed

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)

Benign Prostatic Hypertrophy
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Ejaculation Preservation After Laser Enucleation Prostate (EPALEP)

Prostate Hyperplasia

France
Olympus Surgical Technologies Europe

Terminated

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Benign Prostatic Hypertrophy

China
AEterna Zentaris

Terminated

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

United States, Canada, Bulgaria, Germany
AEterna Zentaris

Completed

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

Netherlands, Belarus, Bulgaria, Czech Republic, France, Germany, Italy, Macedonia, The Former Yugoslav Republic of, Romania, United Kingdom

Clinical Trials on Benign Prostatic Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations